Array BioPharma and Genentech Expand Oncology Collaboration

11-Apr-2005

Array BioPharma announced an expansion of a collaboration agreement with Genentech, Inc. to develop small molecule drugs against an additional protein target in the field of oncology.

The original collaboration, which began in January 2004, was formed to advance two of Array's proprietary oncology programs into clinical development. Under the expanded agreement, Array will receive additional research funding, as well as research and development milestone payments and product royalties based on the success of the new program.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances